Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 74 entries
Sorted by: Best Match Show Resources per page
Survey of Difficult Experiences of Nurses Caring for Patients Undergoing Radiation Therapy: An Analysis of Factors in Difficult Cases.

Asia-Pacific journal of oncology nursing

Tsuchihashi Y, Matsunari Y, Kanamaru Y, Kammen DM.
PMID: 29379840
Asia Pac J Oncol Nurs. 2018 Jan-Mar;5(1):91-98. doi: 10.4103/apjon.apjon_48_17.

OBJECTIVE: The purpose of this study was to analyze the difficult experiences of nurses who cared for patients undergoing radiation therapy and factors related to patient feelings toward the progress and difficulties of treatment and the kind of care...

Cite
Tsuchihashi Y, Matsunari Y, Kanamaru Y, et al. Survey of Difficult Experiences of Nurses Caring for Patients Undergoing Radiation Therapy: An Analysis of Factors in Difficult Cases. Asia Pac J Oncol Nurs. 2018;5(1):91-98doi: 10.4103/apjon.apjon_48_17.
Tsuchihashi, Y., Matsunari, Y., Kanamaru, Y., & Kammen, D. M. (2018). Survey of Difficult Experiences of Nurses Caring for Patients Undergoing Radiation Therapy: An Analysis of Factors in Difficult Cases. Asia-Pacific journal of oncology nursing, 5(1), 91-98. https://doi.org/10.4103/apjon.apjon_48_17
Tsuchihashi, Yumiko, et al. "Survey of Difficult Experiences of Nurses Caring for Patients Undergoing Radiation Therapy: An Analysis of Factors in Difficult Cases." Asia-Pacific journal of oncology nursing vol. 5,1 (2018): 91-98. doi: https://doi.org/10.4103/apjon.apjon_48_17
Tsuchihashi Y, Matsunari Y, Kanamaru Y, Kammen DM. Survey of Difficult Experiences of Nurses Caring for Patients Undergoing Radiation Therapy: An Analysis of Factors in Difficult Cases. Asia Pac J Oncol Nurs. 2018 Jan-Mar;5(1):91-98. doi: 10.4103/apjon.apjon_48_17. PMID: 29379840; PMCID: PMC5763447.
Copy Download .nbib Format: NLM
The Key Ru.

Journal of the American Chemical Society

Lebedev D, Pineda-Galvan Y, Tokimaru Y, Fedorov A, Kaeffer N, Copéret C, Pushkar Y.
PMID: 29219306
J Am Chem Soc. 2018 Jan 10;140(1):451-458. doi: 10.1021/jacs.7b11388. Epub 2017 Dec 20.

Improvement of the oxygen evolution reaction (OER) is a challenging step toward the development of sustainable energy technologies. Enhancing the OER rate and efficiency relies on understanding the water oxidation mechanism, which entails the characterization of the reaction intermediates....

Cite
Lebedev D, Pineda-Galvan Y, Tokimaru Y, et al. The Key Ru. J Am Chem Soc. 2017;140(1):451-458doi: 10.1021/jacs.7b11388.
Lebedev, D., Pineda-Galvan, Y., Tokimaru, Y., Fedorov, A., Kaeffer, N., Copéret, C., & Pushkar, Y. (2018). The Key Ru. Journal of the American Chemical Society, 140(1), 451-458. https://doi.org/10.1021/jacs.7b11388
Lebedev, Dmitry, et al. "The Key Ru." Journal of the American Chemical Society vol. 140,1 (2018): 451-458. doi: https://doi.org/10.1021/jacs.7b11388
Lebedev D, Pineda-Galvan Y, Tokimaru Y, Fedorov A, Kaeffer N, Copéret C, Pushkar Y. The Key Ru. J Am Chem Soc. 2018 Jan 10;140(1):451-458. doi: 10.1021/jacs.7b11388. Epub 2017 Dec 20. PMID: 29219306.
Copy Download .nbib Format: NLM
Case report: Gastric cancer-associated membranous nephropathy that recurred after complete remission and formation of peritoneal dissemination.

Clinical case reports

Kajiwara N, Wada N, Kusumoto T, Akamaru Y, Ohashi H, Hayashi K.
PMID: 30899484
Clin Case Rep. 2019 Feb 06;7(3):515-519. doi: 10.1002/ccr3.2002. eCollection 2019 Mar.

Membranous nephropathy associated with malignant neoplasm may remit completely with treatment of the underlying disease. In such cases, recurrence is very rare. However, after a recurrence, attention should be paid to the possible recurrence of the underlying disease.

Cite
Kajiwara N, Wada N, Kusumoto T, et al. Case report: Gastric cancer-associated membranous nephropathy that recurred after complete remission and formation of peritoneal dissemination. Clin Case Rep. 2019;7(3):515-519doi: 10.1002/ccr3.2002.
Kajiwara, N., Wada, N., Kusumoto, T., Akamaru, Y., Ohashi, H., & Hayashi, K. (2019). Case report: Gastric cancer-associated membranous nephropathy that recurred after complete remission and formation of peritoneal dissemination. Clinical case reports, 7(3), 515-519. https://doi.org/10.1002/ccr3.2002
Kajiwara, Nobuyuki, et al. "Case report: Gastric cancer-associated membranous nephropathy that recurred after complete remission and formation of peritoneal dissemination." Clinical case reports vol. 7,3 (2019): 515-519. doi: https://doi.org/10.1002/ccr3.2002
Kajiwara N, Wada N, Kusumoto T, Akamaru Y, Ohashi H, Hayashi K. Case report: Gastric cancer-associated membranous nephropathy that recurred after complete remission and formation of peritoneal dissemination. Clin Case Rep. 2019 Feb 06;7(3):515-519. doi: 10.1002/ccr3.2002. eCollection 2019 Mar. PMID: 30899484; PMCID: PMC6406138.
Copy Download .nbib Format: NLM
Psychological evaluation for patients with non-cured facial nerve palsy.

Auris, nasus, larynx

Fujiwara K, Fukuda A, Morita S, Yanagi H, Hoshino K, Nakamaru Y, Furuta Y, Homma A.
PMID: 33962818
Auris Nasus Larynx. 2021 May 04; doi: 10.1016/j.anl.2021.04.007. Epub 2021 May 04.

OBJECTIVE: The aim of the present study was to evaluate the psychological condition of patients with non-cured facial nerve palsy and to investigate whether their psychological condition is correlated with the degree of facial nerve palsy, synkinesis or quality...

Cite
Fujiwara K, Fukuda A, Morita S, et al. Psychological evaluation for patients with non-cured facial nerve palsy. Auris Nasus Larynx. 2021;doi: 10.1016/j.anl.2021.04.007.
Fujiwara, K., Fukuda, A., Morita, S., Yanagi, H., Hoshino, K., Nakamaru, Y., Furuta, Y., & Homma, A. (2021). Psychological evaluation for patients with non-cured facial nerve palsy. Auris, nasus, larynx, . https://doi.org/10.1016/j.anl.2021.04.007
Fujiwara, Keishi, et al. "Psychological evaluation for patients with non-cured facial nerve palsy." Auris, nasus, larynx vol. (2021). doi: https://doi.org/10.1016/j.anl.2021.04.007
Fujiwara K, Fukuda A, Morita S, Yanagi H, Hoshino K, Nakamaru Y, Furuta Y, Homma A. Psychological evaluation for patients with non-cured facial nerve palsy. Auris Nasus Larynx. 2021 May 04; doi: 10.1016/j.anl.2021.04.007. Epub 2021 May 04. PMID: 33962818.
Copy Download .nbib Format: NLM
Long-term effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients (KSES002).

Annals of gastroenterological surgery

Kimura Y, Nishikawa K, Kishi K, Inoue K, Matsuyama J, Akamaru Y, Tamura S, Kawada J, Kawase T, Kawabata R, Fujiwara Y, Kanno H, Yamada T, Shimokawa T, Imamura H.
PMID: 31788653
Ann Gastroenterol Surg. 2019 Oct 10;3(6):648-656. doi: 10.1002/ags3.12290. eCollection 2019 Nov.

AIM: The present study aimed to evaluate the efficacy of short-term nutritional intervention with an oral elemental diet (ED; Elental; EA Pharma Co., Ltd, Tokyo, Japan) at 300 kcal/day for 6-8 weeks in the early post-gastrectomy period on postoperative...

Cite
Kimura Y, Nishikawa K, Kishi K, et al. Long-term effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients (KSES002). Ann Gastroenterol Surg. 2019;3(6):648-656doi: 10.1002/ags3.12290.
Kimura, Y., Nishikawa, K., Kishi, K., Inoue, K., Matsuyama, J., Akamaru, Y., Tamura, S., Kawada, J., Kawase, T., Kawabata, R., Fujiwara, Y., Kanno, H., Yamada, T., Shimokawa, T., & Imamura, H. (2019). Long-term effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients (KSES002). Annals of gastroenterological surgery, 3(6), 648-656. https://doi.org/10.1002/ags3.12290
Kimura, Yutaka, et al. "Long-term effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients (KSES002)." Annals of gastroenterological surgery vol. 3,6 (2019): 648-656. doi: https://doi.org/10.1002/ags3.12290
Kimura Y, Nishikawa K, Kishi K, Inoue K, Matsuyama J, Akamaru Y, Tamura S, Kawada J, Kawase T, Kawabata R, Fujiwara Y, Kanno H, Yamada T, Shimokawa T, Imamura H. Long-term effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients (KSES002). Ann Gastroenterol Surg. 2019 Oct 10;3(6):648-656. doi: 10.1002/ags3.12290. eCollection 2019 Nov. PMID: 31788653; PMCID: PMC6875942.
Copy Download .nbib Format: NLM
Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique.

Auris, nasus, larynx

Kimura S, Suzuki M, Honma A, Nakazono A, Osawa M, Nakamaru Y, Homma A.
PMID: 33966932
Auris Nasus Larynx. 2021 May 06; doi: 10.1016/j.anl.2021.04.012. Epub 2021 May 06.

OBJECTIVE: Several methods have been reported to correct caudal deviation of the nasal septum, including open septorhinoplasty (OSR) and septoplasty with Killian incision (KI). In general, OSR is applied instead of KI for caudal deviation. However, there is little...

Cite
Kimura S, Suzuki M, Honma A, et al. Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique. Auris Nasus Larynx. 2021;doi: 10.1016/j.anl.2021.04.012.
Kimura, S., Suzuki, M., Honma, A., Nakazono, A., Osawa, M., Nakamaru, Y., & Homma, A. (2021). Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique. Auris, nasus, larynx, . https://doi.org/10.1016/j.anl.2021.04.012
Kimura, Shogo, et al. "Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique." Auris, nasus, larynx vol. (2021). doi: https://doi.org/10.1016/j.anl.2021.04.012
Kimura S, Suzuki M, Honma A, Nakazono A, Osawa M, Nakamaru Y, Homma A. Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique. Auris Nasus Larynx. 2021 May 06; doi: 10.1016/j.anl.2021.04.012. Epub 2021 May 06. PMID: 33966932.
Copy Download .nbib Format: NLM
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.

Diagnostics (Basel, Switzerland)

On J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y.
PMID: 33918936
Diagnostics (Basel). 2021 Apr 09;11(4). doi: 10.3390/diagnostics11040681.

Recent studies have suggested the feasibility of detecting H3K27M mutations in the cerebrospinal fluid of diffuse midline glioma (DMG) patients. However, cerebrospinal fluid from patients in these studies were collected mainly during biopsy, ventriculo-peritoneal shunt procedures or postmortem. We...

Cite
On J, Natsumeda M, Watanabe J, et al. Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas. Diagnostics (Basel). 2021;11(4)doi: 10.3390/diagnostics11040681.
On, J., Natsumeda, M., Watanabe, J., Saito, S., Kanemaru, Y., Abe, H., Tsukamoto, Y., Okada, M., Oishi, M., Yoshimura, J., Kakita, A., & Fujii, Y. (2021). Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas. Diagnostics (Basel, Switzerland), 11(4), . https://doi.org/10.3390/diagnostics11040681
On, Jotaro, et al. "Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas." Diagnostics (Basel, Switzerland) vol. 11,4 (2021). doi: https://doi.org/10.3390/diagnostics11040681
On J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y. Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas. Diagnostics (Basel). 2021 Apr 09;11(4). doi: 10.3390/diagnostics11040681. PMID: 33918936; PMCID: PMC8070169.
Copy Download .nbib Format: NLM
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Yamasaki M, Takiguchi S, Omori T, Hirao M, Imamura H, Fujitani K, Tamura S, Akamaru Y, Kishi K, Fujita J, Hirao T, Demura K, Matsuyama J, Takeno A, Ebisui C, Takachi K, Takayama O, Fukunaga H, Okada K, Adachi S, Fukuda S, Matsuura N, Saito T, Takahashi T, Kurokawa Y, Yano M, Eguchi H, Doki Y.
PMID: 33118118
Gastric Cancer. 2021 Mar;24(2):535-543. doi: 10.1007/s10120-020-01129-6. Epub 2020 Oct 29.

BACKGROUND: The appropriate surgical procedure for patients with upper third early gastric cancer is controversial. We compared total gastrectomy (TG) with proximal gastrectomy (PG) in this patient population.METHODS: A multicenter, non-randomized trial was conducted, with patients treated with PG...

Cite
Yamasaki M, Takiguchi S, Omori T, et al. Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer. Gastric Cancer. 2020;24(2):535-543doi: 10.1007/s10120-020-01129-6.
Yamasaki, M., Takiguchi, S., Omori, T., Hirao, M., Imamura, H., Fujitani, K., Tamura, S., Akamaru, Y., Kishi, K., Fujita, J., Hirao, T., Demura, K., Matsuyama, J., Takeno, A., Ebisui, C., Takachi, K., Takayama, O., Fukunaga, H., Okada, K., Adachi, S., Fukuda, S., Matsuura, N., Saito, T., Takahashi, T., Kurokawa, Y., Yano, M., Eguchi, H., & Doki, Y. (2021). Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 24(2), 535-543. https://doi.org/10.1007/s10120-020-01129-6
Yamasaki, Makoto, et al. "Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 24,2 (2021): 535-543. doi: https://doi.org/10.1007/s10120-020-01129-6
Yamasaki M, Takiguchi S, Omori T, Hirao M, Imamura H, Fujitani K, Tamura S, Akamaru Y, Kishi K, Fujita J, Hirao T, Demura K, Matsuyama J, Takeno A, Ebisui C, Takachi K, Takayama O, Fukunaga H, Okada K, Adachi S, Fukuda S, Matsuura N, Saito T, Takahashi T, Kurokawa Y, Yano M, Eguchi H, Doki Y. Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer. Gastric Cancer. 2021 Mar;24(2):535-543. doi: 10.1007/s10120-020-01129-6. Epub 2020 Oct 29. PMID: 33118118.
Copy Download .nbib Format: NLM
Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line.

American journal of cancer research

Takaoka E, Sonobe H, Akimaru K, Sakamoto S, Shuin T, Daibata M, Taguchi T, Tominaga A.
PMID: 22432055
Am J Cancer Res. 2012;2(2):141-52. Epub 2012 Feb 19.

A molecular cytogenetic analysis was performed on HS-RMS-2, a cell line established in this laboratory from a rare pleomorphic type of rhabdomyosarcoma. G-banding and multicolor-FISH analyses revealed that the cells have a complex chromosomal composition. Comparative genomic in situ...

Cite
Takaoka E, Sonobe H, Akimaru K, et al. Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line. Am J Cancer Res. 2012;2(2):141-52
Takaoka, E., Sonobe, H., Akimaru, K., Sakamoto, S., Shuin, T., Daibata, M., Taguchi, T., & Tominaga, A. (2012). Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line. American journal of cancer research, 2(2), 141-52.
Takaoka, Eiji, et al. "Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line." American journal of cancer research vol. 2,2 (2012): 141-52.
Takaoka E, Sonobe H, Akimaru K, Sakamoto S, Shuin T, Daibata M, Taguchi T, Tominaga A. Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line. Am J Cancer Res. 2012;2(2):141-52. Epub 2012 Feb 19. PMID: 22432055; PMCID: PMC3304565.
Copy Download .nbib Format: NLM
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.

Frontiers in oncology

Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, Yoshimura J, Oishi M, Hashizume R, Kakita A, Fujii Y.
PMID: 32039031
Front Oncol. 2020 Jan 21;9:1568. doi: 10.3389/fonc.2019.01568. eCollection 2019.

Diffuse midline gliomas (DMGs) show resistance to many chemotherapeutic agents including temozolomide (TMZ). Histone gene mutations in DMGs trigger epigenetic changes including DNA hypomethylation, one of which is a frequent lack of O6-methyl-guanine-DNA methyltransferase (

Cite
Abe H, Natsumeda M, Okada M, et al. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Front Oncol. 2020;9:1568doi: 10.3389/fonc.2019.01568.
Abe, H., Natsumeda, M., Okada, M., Watanabe, J., Tsukamoto, Y., Kanemaru, Y., Yoshimura, J., Oishi, M., Hashizume, R., Kakita, A., & Fujii, Y. (2019). MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Frontiers in oncology, 91568. https://doi.org/10.3389/fonc.2019.01568
Abe, Hideaki, et al. "MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas." Frontiers in oncology vol. 9 (2019): 1568. doi: https://doi.org/10.3389/fonc.2019.01568
Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, Yoshimura J, Oishi M, Hashizume R, Kakita A, Fujii Y. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Front Oncol. 2020 Jan 21;9:1568. doi: 10.3389/fonc.2019.01568. eCollection 2019. PMID: 32039031; PMCID: PMC6985080.
Copy Download .nbib Format: NLM
Tautomerism-Induced Cis-Trans Isomerization of Pyridylethenyl N-Confused Porphyrin.

The Journal of organic chemistry

Sakashita R, Oka Y, Akimaru H, Kesavan PE, Ishida M, Toganoh M, Ishizuka T, Mori S, Furuta H.
PMID: 28745048
J Org Chem. 2017 Aug 18;82(16):8686-8696. doi: 10.1021/acs.joc.7b01770. Epub 2017 Jul 31.

Pyridylethenyl-substituted N-confused porphyrins (NCPs) were synthesized, and their cis-trans isomerization was studied. Among four possible isomers, trans-3H and cis-2H types of structures, of which aromaticity and absorption/emission properties differ largely, were isolated. The cis-isomer was largely stabilized by the...

Cite
Sakashita R, Oka Y, Akimaru H, et al. Tautomerism-Induced Cis-Trans Isomerization of Pyridylethenyl N-Confused Porphyrin. J Org Chem. 2017;82(16):8686-8696doi: 10.1021/acs.joc.7b01770.
Sakashita, R., Oka, Y., Akimaru, H., Kesavan, P. E., Ishida, M., Toganoh, M., Ishizuka, T., Mori, S., & Furuta, H. (2017). Tautomerism-Induced Cis-Trans Isomerization of Pyridylethenyl N-Confused Porphyrin. The Journal of organic chemistry, 82(16), 8686-8696. https://doi.org/10.1021/acs.joc.7b01770
Sakashita, Ryuichi, et al. "Tautomerism-Induced Cis-Trans Isomerization of Pyridylethenyl N-Confused Porphyrin." The Journal of organic chemistry vol. 82,16 (2017): 8686-8696. doi: https://doi.org/10.1021/acs.joc.7b01770
Sakashita R, Oka Y, Akimaru H, Kesavan PE, Ishida M, Toganoh M, Ishizuka T, Mori S, Furuta H. Tautomerism-Induced Cis-Trans Isomerization of Pyridylethenyl N-Confused Porphyrin. J Org Chem. 2017 Aug 18;82(16):8686-8696. doi: 10.1021/acs.joc.7b01770. Epub 2017 Jul 31. PMID: 28745048.
Copy Download .nbib Format: NLM
Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma.

Oncology letters

Kakizaki T, Hatakeyama H, Nakamaru Y, Takagi D, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S.
PMID: 28693263
Oncol Lett. 2017 Jul;14(1):987-992. doi: 10.3892/ol.2017.6193. Epub 2017 May 17.

Inverted papilloma (IP) is a benign tumor occurring in the nasal cavity and paranasal sinuses. It is reported that 5-15% of IPs undergo malignant transformation into squamous cell carcinoma (SCC), and the role of microRNAs (miRNA/miR) in this process...

Cite
Kakizaki T, Hatakeyama H, Nakamaru Y, et al. Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma. Oncol Lett. 2017;14(1):987-992doi: 10.3892/ol.2017.6193.
Kakizaki, T., Hatakeyama, H., Nakamaru, Y., Takagi, D., Mizumachi, T., Sakashita, T., Kano, S., Homma, A., & Fukuda, S. (2017). Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma. Oncology letters, 14(1), 987-992. https://doi.org/10.3892/ol.2017.6193
Kakizaki, Tomohiko, et al. "Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma." Oncology letters vol. 14,1 (2017): 987-992. doi: https://doi.org/10.3892/ol.2017.6193
Kakizaki T, Hatakeyama H, Nakamaru Y, Takagi D, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S. Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma. Oncol Lett. 2017 Jul;14(1):987-992. doi: 10.3892/ol.2017.6193. Epub 2017 May 17. PMID: 28693263; PMCID: PMC5494725.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 74 entries